GLSI
GRNWICH LIFESCI (GLSI)
NASDAQ
$23.92-$0.37 (-1.52%)
Price as of Jun 03, 2026 7:49 PM EDT
  • $362.6M
    Market Cap
  • 154.35%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
434,732
0.00%
434,732
N/A
Gross Profit
0
N/A
0
+100.00%
-434,732
0.00%
-434,732
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-13.0M
+68.24%
-7.7M
+18.89%
-6.5M
+81.93%
-3.6M
+236.56%
Depreciation and Amortization Expense
3,612
0.00%
3,612
0.00%
3,612
0.00%
3,612
+0.08%
Total Operating Expenses
16.0M
+71.66%
9.3M
+16.01%
8.0M
+74.87%
4.6M
+146.70%
Operating Profit
-16.0M
+71.66%
-9.3M
+16.01%
-8.0M
+74.87%
-4.6M
+146.70%
Interest Income
223,008
-48.86%
436,063
+102.80%
215,017
+685.68%
27,367
+3,189.30%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
223,008
-48.86%
436,063
+102.80%
215,017
+685.68%
27,367
+3,189.30%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-16.0M
+71.66%
-9.3M
+16.01%
-8.0M
+74.87%
-4.6M
+146.70%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-15.8M
+77.57%
-8.9M
+13.63%
-7.8M
+71.21%
-4.6M
+145.34%
Net Income from Continuing Operations Applicable to Common
-15.8M
+77.57%
-8.9M
+13.63%
-7.8M
+71.21%
-4.6M
+145.34%
Basic EPS and Net Income
-1.21
+75.36%
-0.69
+13.11%
-0.61
+74.29%
-0.35
+75.00%
Diluted EPS and Net Income
-1.21
+75.36%
-0.69
+13.11%
-0.61
+74.29%
-0.35
+75.00%
Basic Weighted Average Shares
13.0M
+1.30%
12.8M
-0.51%
12.9M
-0.23%
12.9M
+36.27%
Diluted Weighted Average Shares
13.0M
+1.30%
12.8M
N/A
N/A
N/A
12.9M
+36.27%
Balance Sheet
Cash and Cash Equivalents
4.1M
-41.45%
7.0M
-48.10%
13.5M
-50.49%
27.2M
-5.08%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
4.1M
-41.45%
7.0M
-48.10%
13.5M
-50.49%
27.2M
-5.08%
Total Current Assets
4.1M
-41.45%
7.0M
-48.10%
13.5M
-50.49%
27.2M
-5.08%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
4.1M
-41.47%
7.0M
-48.10%
13.5M
-50.48%
27.2M
-5.09%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
275,154
0.00%
275,154
0.00%
Total Current Liabilities
1.6M
+429.79%
294,406
+11.98%
262,905
-31.74%
385,172
-63.16%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
81,553
+21.30%
67,230
-58.41%
161,644
-53.26%
345,833
-88.29%
Total Liabilities
1.6M
+429.79%
294,406
+11.98%
262,905
-31.74%
385,172
-63.16%
Retained Earnings
-66.2M
+31.35%
-50.4M
+21.44%
-41.5M
+23.26%
-33.6M
+15.72%
Total Stockholders Equity
2.5M
-62.18%
6.7M
-49.29%
13.2M
-50.75%
26.8M
-2.89%
Total Shares Outstanding
13.2M
+2.37%
12.8M
0.00%
12.8M
-2.28%
13.1M
+3.50%
Cash Flow
Cash from Operating Activities
-7.3M
+12.16%
-6.5M
+4.49%
-6.2M
+44.47%
-4.3M
+272.22%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4.4M
N/A
N/A
N/A
-7.5M
-365.79%
2.8M
-90.49%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-284.78%
+227.82%
-86.87%
+125.87%
-38.46%
+135.16%
-16.35%
N/A
Return on Equity
-341.95%
+282.93%
-89.30%
+128.50%
-39.08%
+132.85%
-16.78%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.62
-88.95%
23.74
-53.66%
51.23
-27.47%
70.63
N/A
Cash Ratio
2.62
-88.95%
23.74
-53.66%
51.23
-27.47%
70.63
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow